￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is the Laotian version of Sotorasibu effective? Comparative analysis of effects and genuine products

2026-02-01 22:25:32

Check Details
Adagrasiib/cetuximab maintains efficacy in KRAS G12C mutated advanced mCRC

2026-02-01 22:25:32

Check Details
What are the side effects of afatinib? How to deal with it scientifically?

2026-02-01 22:25:32

Check Details
Latest news on DaliRasen in 2025: price, medical insurance and clinical progress

2026-02-01 22:25:32

Check Details
Pembrolizumab combined with olaparib improves PFS in BRCA wild-type ovarian cancer

2026-02-01 22:25:32

Check Details
Acolitinib plus venetoclax and otuzumab show high level of activity in first-line high-risk CLL

2026-02-01 22:25:32

Check Details
Aceminid usage and dosage guide: How to take it scientifically to achieve the best effect?

2026-02-01 22:25:32

Check Details
Ritexitinib combined with nbUVB enhances pigmentation in patients with vitiligo

2026-02-01 22:25:32

Check Details
What is the market price of sparsentan/sparsentan? Latest selling prices and medical insurance coverage in 2025

2026-02-01 22:25:32

Check Details
Is ixazomib/enleri less effective than bortezomib? Comparison of the efficacy of two drugs

2026-02-01 22:25:32

Check Details
When will Canafenib be launched in China? Latest approval progress and market launch forecast

2026-02-01 22:25:32

Check Details
The role and efficacy of sotorasib: analysis of indications and treatment principles

2026-02-01 22:25:32

Check Details
Category
相关知识